Cetuximab and hypomagnesaemia 
Cetuximab and hypomagnesaemia Patient Reports February 11, 2012
Cetuximab Side Effects Report #5369040-2
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on June 21, 2007. Male patient, 71 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypomagnesaemia, pneumonia
, thrombocytopenia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4774908-1
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Sept 09, 2005. Male patient, 71 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: bone marrow depression, febrile neutropenia, hypocalcaemia, hypomagnesaemia, pneumonia
, septic shock, thrombocytopenia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4785006-5
Cetuximab side effect was reported by a Health Professional from GERMANY on Sept 26, 2005. Male patient, 71 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypocalcaemia, hypomagnesaemia, pneumonia
, septic shock, thrombocytopenia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 09/09/2005.Cetuximab Side Effects Report #4949296-8
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Sept 09, 2005. Male patient, 71 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypocalcaemia, hypomagnesaemia, pneumonia
, septic shock, thrombocytopenia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4894487-8
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 20, 2006. Female patient, 70 years of age, weighting 152.1 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: electrolyte imbalance, hypocalcaemia, hypokalaemia, hypomagnesaemia, loss of consciousness, muscle rigidity, neutropenia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4877856-1
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Dec 16, 2005. Female patient, 68 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal pain
, dehydration, hypokalaemia, hypomagnesaemia, infection , nausea . Cetuximab dosage: 400 MG/M2 ON 31-OCT-2005 F/B 250 MG/M2.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4906171-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Dec 16, 2005. Female patient, 68 years of age, weighting 108.0 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal pain
, asthenia, clostridium colitis, dehydration, dermatitis, hypokalaemia, hypomagnesaemia, infection , nausea . Cetuximab dosage: 400 MG/M2 ON 31-OCT-2005 F/B 250 MG/M2.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4939971-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Dec 16, 2005. Female patient, 68 years of age, weighting 108.0 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal pain
, asthenia, clostridium colitis, dehydration, dermatitis, hypokalaemia, hypomagnesaemia, infection , nausea . Cetuximab dosage: 400 MG/M2 ON 31-OCT-2005 F/B 250 MG/M2.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4868028-5
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2005. Male patient, 67 years of age, weighting 154.3 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, hypomagnesaemia, rash
, stomatitis. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4944637-X
Cetuximab side effect was reported by a Health Professional from GERMANY on Mar 03, 2006. Male patient, 64 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4950326-8
Cetuximab side effect was reported by a Health Professional from GERMANY on Mar 03, 2006. Male patient, 64 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5264570-6
Cetuximab side effect was reported by a Health Professional from IRELAND on Mar 07, 2007. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5267132-X
Cetuximab side effect was reported by a Health Professional from GERMANY on Mar 07, 2007. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: fatigue, hypokalaemia, hypomagnesaemia, hypophosphataemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL, WARFARIN, DILTIAZEM, PANTOPRAZOLE, SIMVASTATIN, DUOVENT, ONDANSETRON. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5369625-3
Cetuximab side effect was reported by a Health Professional from GERMANY on June 21, 2007. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5372435-4
Cetuximab side effect was reported by a Health Professional from GERMANY on June 21, 2007. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: fatigue, hypokalaemia, hypomagnesaemia, hypophosphataemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL, WARFARIN, DILTIAZEM, PANTOPRAZOLE, SIMVASTATIN, DUOVENT, ONDANSETRON. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5671306-3
Cetuximab side effect was reported by a Health Professional from GERMANY on Mar 03, 2008. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: fatigue, hypokalaemia, hypomagnesaemia, hypophosphataemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL, WARFARIN, DILTIAZEM, PANTOPRAZOLE, SIMVASTATIN, DUOVENT, ONDANSETRON. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4753716-1
Cetuximab side effect was reported by a Health Professional from IRELAND on Aug 16, 2005. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4771952-5
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Sept 08, 2005. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: fatigue, hypokalaemia, hypomagnesaemia, hypophosphataemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4805853-0
Cetuximab side effect was reported by a Health Professional from GERMANY on Sept 08, 2005. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: fatigue, hypokalaemia, hypomagnesaemia, hypophosphataemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4811519-3
Cetuximab side effect was reported by a Physician from BELGIUM on Oct 11, 2005. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: fatigue, hypokalaemia, hypomagnesaemia, hypophosphataemia, performance status decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4922437-4
Cetuximab side effect was reported by a Health Professional from GERMANY on Sept 08, 2005. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: fatigue, hypokalaemia, hypomagnesaemia, hypophosphataemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4712290-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on June 20, 2005. Male patient, 58 years of age, weighting 158.7 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia, pyrexia, rash
. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DECADRON, BENADRYL, ANZEMET, ZOSYN, GATIFLOXACIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5509017-7
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient, 52 years of age, weighting 125.7 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, granulocyte count decreased, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypokalaemia, hypomagnesaemia, hyponatraemia, oral pain. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5322599-3
Cetuximab side effect was reported by a Health Professional from GERMANY on Apr 30, 2007. Male patient, 70 years of age, was diagnosed with rectal cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: convulsion, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with ELOXATIN, XELODA. Patient recovered.
Cetuximab Side Effects Report #4554559-4
Cetuximab side effect was reported by a Consumer or non-health professional from on Jan 12, 2005. Male patient, 69 years of age, weighting 202.8 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia. Cetuximab dosage: ARM B.1ST GIVEN 02-FEB-04. TOTAL DOSE THIS COURSE 3090 MG (COURSE 8). 27-DEC-04 DOSE DELAYED.. During the same period patient was treated with DOCETAXEL, IRINOTECAN, ENOXAPARIN. Patient recovered.
Cetuximab Side Effects Report #4575971-3
Cetuximab side effect was reported by a Health Professional from on Feb 02, 2005. Male patient, 69 years of age, weighting 202.8 lb, was diagnosed with pancreatic carcinoma, prophylaxis and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with DOCETAXEL, IRINOTECAN, ENOXAPARIN. Patient recovered.
Cetuximab Side Effects Report #4640576-2
Cetuximab side effect was reported by a Consumer or non-health professional from on Apr 13, 2005. Female patient, 57 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: diarrhoea, hypocalcaemia, hypokalaemia, hypomagnesaemia. Cetuximab dosage: 1ST CETUXIMAB COURSE 28-DEC-2004. CETUXIMAB 250 MG/M2 WEEKLY EVERY 28 DAY CYCLE. DELAYED 7 DAYS.. During the same period patient was treated with GEMCITABINE. Patient recovered.
Cetuximab Side Effects Report #4550570-8
Cetuximab side effect was reported by a Consumer or non-health professional from on Jan 06, 2005. Female patient, 61 years of age, was diagnosed with ovarian cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DURAGESIC. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5931455-9
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Oct 21, 2008. Female patient, 63 years of age, was diagnosed with oesophageal carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dysphagia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, DOCETAXEL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5493068-5
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 19, 2007. Female patient, 62 years of age, weighting 145.5 lb, was diagnosed with non-small cell lung cancer recurrent and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, hypomagnesaemia, respiratory failure, tachycardia. Cetuximab dosage: unknown. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5248042-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer metastatic, coronary artery disease
, blood cholesterol, back pain , dyspnoea and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: diarrhoea, hypomagnesaemia, renal failure. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATACAND, LASIX, ATORVASTATIN, VICODIN, PROVENTIL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4743811-5
Cetuximab side effect was reported by a Health Professional from UNITED STATES on June 13, 2005. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ADVAIR DISKUS, DIOVAN, DOXAZOSIN, FUROSEMIDE, GUANETHIDINE SULPHATE, LISINOPRIL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4747506-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on July 21, 2005. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer, hypertension and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, CIPROFLOXACIN, NORVASC, PREDNISONE, ZOFRAN. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4862628-4
Cetuximab side effect was reported by a Health Professional from UNITED STATES on July 21, 2005. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer, hypertension and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, CIPROFLOXACIN, NORVASC, PREDNISONE, ZOFRAN. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4746117-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 27, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus non-insulin-dependent, hypomagnesaemia, vomiting and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, blood sodium decreased, disease progression, extrasystoles, hypomagnesaemia, malignant neoplasm progression, supraventricular extrasystoles, ventricular arrhythmia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, LISINOPRIL, HYDROCHLOROTHIAZIDE, GLYBURIDE, MAGNESIUM OXIDE, AVANDIA, COMPAZINE, TYLENOL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4657783-5
Cetuximab side effect was reported by a Consumer or non-health professional from on May 03, 2005. Male patient, 69 years of age, weighting 205.0 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia, hypotension, pneumonia
, sepsis , sputum culture positive, streptococcal infection , upper respiratory tract infection, ventricular tachycardia. Cetuximab dosage: 7205.5 MG ADMINISTERED THIS COURSE.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4664890-X
Cetuximab side effect was reported by a Health Professional from on May 05, 2005. Female patient, 68 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, anaemia, intravenous catheter management, antiemetic supportive care and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, hypokalaemia, hypomagnesaemia, hypotension, lung neoplasm malignant, supraventricular tachycardia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, ARANESP, HEPARIN, ZANTAC, DECADRON, ALOXI. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4701340-9
Cetuximab side effect was reported by a Health Professional from on May 05, 2005. Female patient, 68 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, anaemia, intravenous catheter management, antiemetic supportive care and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, chest pain
, cough, dyspnoea, hypokalaemia, hypomagnesaemia, hypotension, lung neoplasm malignant, painful respiration. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, ARANESP, HEPARIN, ZANTAC, DECADRON, ALOXI. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4714730-5
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 05, 2005. Female patient, 68 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, anaemia, intravenous catheter management, antiemetic supportive care and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, hypomagnesaemia, hypotension, pleural effusion, supraventricular tachycardia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, ARANESP, HEPARIN, ZANTAC, DECADRON, ALOXI. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4721939-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 05, 2005. Female patient, 68 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, anaemia, intravenous catheter management, antiemetic supportive care and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, hypomagnesaemia, hypotension, malignant neoplasm progression, pleural effusion, supraventricular tachycardia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, ARANESP, HEPARIN, ZANTAC, DECADRON, ALOXI. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4742535-8
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 05, 2005. Female patient, 68 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, anaemia, intravenous catheter management, antiemetic supportive care and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, hypomagnesaemia, hypotension, pleural effusion, supraventricular tachycardia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, ARANESP, HEPARIN, ZANTAC, DECADRON, ALOXI. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4708013-7
Cetuximab side effect was reported by a Health Professional from UNITED STATES on June 29, 2005. Female patient, 66 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: chest pain
, dysphagia, febrile neutropenia, hypomagnesaemia. Cetuximab dosage: INITIAL TX DATE: 28-FEB-05. 8383 MG:TOTAL DOSE ADM THIS COURSE.. During the same period patient was treated with TAXOL, CARBOPLATIN, FERROUS SULPHATE, MAGNESIUM, POTASSIUM CHLORIDE, MYCOSTATIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5194962-5
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 22, 2005. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, LOPRESSOR, SYNTHROID, BENAZEPRIL, CENTRUM SILVER, ASPIRIN, LIPITOR. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4839948-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 22, 2005. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, LOPRESSOR, SYNTHROID, BENAZEPRIL, CENTRUM SILVER, ASPIRIN, LIPITOR. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4943345-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 22, 2005. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, LOPRESSOR, SYNTHROID, BENAZEPRIL, CENTRUM SILVER, ASPIRIN, LIPITOR. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5215997-X
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, febrile neutropenia, haematocrit decreased, haemoglobin decreased, heart rate increased, heart rate irregular, hypokalaemia, hypomagnesaemia, hyponatraemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, DURAGESIC, OXYCODONE, MAXIPIME, VANCOMYCIN, PROTONIX. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4761604-X
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 30, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, hypomagnesaemia, hyponatraemia, small intestinal obstruction. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, DURAGESIC, OXYCODONE, NEUPOGEN, XANAX. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4764528-7
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 30, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, hypomagnesaemia, hyponatraemia, ileus. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, DURAGESIC, OXYCODONE, NEUPOGEN, XANAX. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4808461-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 30, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, febrile neutropenia, hypokalaemia, hypomagnesaemia, hyponatraemia, ileus. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, DURAGESIC, OXYCODONE, NEUPOGEN, XANAX. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4896395-5
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 30, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, febrile neutropenia, hypokalaemia, hypomagnesaemia, hyponatraemia, ileus. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, DURAGESIC, OXYCODONE, MAXIPIME, VANCOMYCIN, PROTONIX. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4901342-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 30, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, febrile neutropenia, hypokalaemia, hypomagnesaemia, hyponatraemia, ileus. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, DURAGESIC, OXYCODONE, MAXIPIME, VANCOMYCIN, PROTONIX. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5342434-7
Cetuximab side effect was reported by a Health Professional from GERMANY on May 30, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer, metastases to bone, hypertension, pain
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, hypocalcaemia, hypomagnesaemia, neutropenic sepsis. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE, ZOLEDRONIC ACID, MEGESTROL ACETATE, AMLODIPINE, FENTANYL, NYSTATIN, DEXAMETHASONE. Patient was hospitalized. Patient died on 11/03/2005.Cetuximab Side Effects Report #5270818-4
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Mar 19, 2007. Female patient, 58 years of age, weighting 233.7 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anxiety
, dehydration, depression , gastritis, hypokalaemia, hypomagnesaemia, lactic acidosis, leukocytosis, troponin increased. Cetuximab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, BEVACIZUMAB. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4582719-5
Cetuximab side effect was reported by a Health Professional from on Feb 08, 2005. Male patient, 58 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, fatigue, haemoglobin decreased, hypomagnesaemia, orthostatic hypotension, platelet count decreased, syncope, vertigo. Cetuximab dosage: INITIAL TX DATE:12-OCT-04/6488MG WAS TOTAL DOSE ADM THIS COURSE/LAST CYCLE HELD/NOT TO BE MADE UP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4601660-2
Cetuximab side effect was reported by a Health Professional from on Feb 08, 2005. Male patient, 58 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, fatigue, haemoglobin decreased, hypomagnesaemia, platelet count decreased, syncope. Cetuximab dosage: INITIAL TX DATE:12-OCT-04/6488MG WAS TOTAL DOSE ADM THIS COURSE/LAST CYCLE HELD/NOT TO BE MADE UP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5262923-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Mar 08, 2007. Male patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, hypomagnesaemia, pleural effusion. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5535230-9
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Nov 30, 2007. Male patient, 56 years of age, was diagnosed with non-small cell lung cancer, hypermagnesaemia and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, hypomagnesaemia, palpitations, supraventricular tachycardia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE, PIDOMAG. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4876111-3
Cetuximab side effect was reported by a Physician from UNITED STATES on Jan 06, 2006. Female patient, 68 years of age, weighting 109.0 lb, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal pain
, bacteria stool identified, clostridial infection, dehydration, hypokalaemia, hypomagnesaemia, nausea , pyrexia. Cetuximab dosage: 400MG/M2 - 580MG (X 1 DOSE) IV. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5129453-0
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 29, 2006. Male patient, 62 years of age, weighting 145.5 lb, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, haemoglobin, hypomagnesaemia, mucosal inflammation, pyrexia, rash
, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, BACTROBAN, DILAUDID, POTASSIUM, MAGNESIUM CHLORIDE, NEUPOGEN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5729185-1
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Apr 30, 2008. Male patient, 60 years of age, weighting 198.4 lb, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: constipation
, dehydration, dysphagia, hypomagnesaemia, hypophosphataemia, mucosal inflammation, nausea , oral pain, stomatitis. Cetuximab dosage: START DATE OF FIRST COURSE = 12MAR08;COURSES TODATE-6 LOADING DOSE 400 MG/M2;250 MG/M2 WEEKLY. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5400579-7
Cetuximab side effect was reported by a Health Professional from UNITED STATES on July 25, 2007. Male patient, 51 years of age, weighting 207.2 lb, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dizziness
, haemolytic anaemia, hyperglycaemia, hypokalaemia, hypomagnesaemia, infection , leukopenia, mucosal inflammation, rash . Cetuximab dosage: CETUXIMAB400MG/M2 INITIAL250MG/M2 1-7. During the same period patient was treated with CISPLATIN, FENTANYL, STEROIDS. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5210358-1
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2007. Female patient, 37 years of age, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5214071-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2007. Female patient, 37 years of age, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypokalaemia, hypomagnesaemia, nausea
. Cetuximab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5394405-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on July 20, 2007. Female patient, 17 years of age, was diagnosed with neoplasm and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, diarrhoea, febrile neutropenia, haemoglobin, hypocalcaemia, hypokalaemia, hypomagnesaemia, nausea
, neutrophil count. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5399206-7
Cetuximab side effect was reported by a Health Professional from UNITED STATES on July 25, 2007. Female patient, 17 years of age, was diagnosed with neoplasm and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, diarrhoea, febrile neutropenia, haemoglobin, hypocalcaemia, hypokalaemia, hypomagnesaemia, nausea
, neutrophil count. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5481681-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2007. Female patient, 17 years of age, was diagnosed with neoplasm and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, diarrhoea, febrile neutropenia, haemoglobin decreased, hypocalcaemia, hypokalaemia, hypomagnesaemia, nausea
, neutrophil count decreased. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4761757-3
Cetuximab side effect was reported by a Health Professional from GERMANY on Aug 24, 2005. Female patient, 54 years of age, was diagnosed with metastatic squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypomagnesaemia, vomiting. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4820435-2
Cetuximab side effect was reported by a Health Professional from GERMANY on Aug 24, 2005. Female patient, 54 years of age, was diagnosed with metastatic squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia, vomiting. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4627193-5
Cetuximab side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 52 years of age, weighting 207.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypokalaemia, hypomagnesaemia, muscle spasms. Cetuximab dosage: unknown. During the same period patient was treated with ERLOTINIB, LASIX, ZOMETA. Patient recovered.
Cetuximab Side Effects Report #5612513-5
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 31, 2008. Male patient, 67 years of age, was diagnosed with metastatic gastric cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #6050414-1
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2009. Male patient, weighting 213.0 lb, was diagnosed with lung neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia, pneumonia
, supraventricular tachycardia. Cetuximab dosage: unknown. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #6050543-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2009. Male patient, weighting 213.0 lb, was diagnosed with lung neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia, pneumonia
, supraventricular tachycardia. Cetuximab dosage: unknown. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5233804-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Female patient, 71 years of age, was diagnosed with lung cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, dyspnoea, hypokalaemia, hypomagnesaemia, hyponatraemia, hypotension, neutropenia, septic shock, skin lesion. Cetuximab dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5128773-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2006. Male patient, 59 years of age, weighting 149.9 lb, was diagnosed with laryngeal cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, hypoalbuminaemia, hypomagnesaemia, hyponatraemia, neutrophil count decreased, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5863941-4
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2008. Female patient, 68 years of age, weighting 108.0 lb, was diagnosed with head and neck cancer
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, haemoglobinaemia, hypoalbuminaemia, hypocalcaemia, hypokalaemia, hypomagnesaemia, hypotension, lymphopenia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #6086142-6
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Feb 13, 2009. Female patient, 61 years of age, was diagnosed with head and neck cancer
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #6066871-0
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 02, 2009. Male patient, 51 years of age, weighting 207.2 lb, was diagnosed with head and neck cancer
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dizziness , haemolytic anaemia, hyperglycaemia, hypokalaemia, hypomagnesaemia, infection , leukopenia, mucosal inflammation, rash . Cetuximab dosage: CETUXIMAB400MG/M2 INITIAL250MG/M2 1-7. During the same period patient was treated with CISPLATIN, FENTANYL, STEROIDS. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5839746-7
Cetuximab side effect was reported by a Health Professional from GERMANY on July 31, 2008. Male patient, 80 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, diarrhoea, hypocalcaemia, hypomagnesaemia. Cetuximab dosage: CETUXIMAB 2 MG/ML. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5905724-2
Cetuximab side effect was reported by a Health Professional from GERMANY on Sept 26, 2008. Male patient, 80 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, diarrhoea, hypocalcaemia, hypomagnesaemia. Cetuximab dosage: CETUXIMAB 2 MG/ML. During the same period patient was treated with IRINOTECAN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4686053-4
Cetuximab side effect was reported by a Health Professional from on June 06, 2005. Female patient, 78 years of age, weighting 105.8 lb, was diagnosed with colorectal cancer metastatic, thrombosis, diarrhoea and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia. Cetuximab dosage: INITIAL DOSE 592 MG ADMINSTERED ON 10-MAY-2005 F/B 370 MG WEEKLY.. During the same period patient was treated with DALTEPARIN, LOMOTIL. Patient recovered.
Cetuximab Side Effects Report #4827509-0
Cetuximab side effect was reported by a Health Professional from CANADA on June 06, 2005. Female patient, 78 years of age, weighting 105.8 lb, was diagnosed with colorectal cancer metastatic, thrombosis, diarrhoea and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia. Cetuximab dosage: INITIAL DOSE 592 MG ADMINSTERED ON 10-MAY-2005 F/B 370 MG WEEKLY.. During the same period patient was treated with DALTEPARIN, LOMOTIL. Patient recovered.
Cetuximab Side Effects Report #5214064-9
Cetuximab side effect was reported by a Health Professional from GERMANY on Jan 12, 2007. Male patient, 75 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4788849-7
Cetuximab side effect was reported by a Health Professional from GERMANY on Sept 23, 2005. Male patient, 75 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, hypomagnesaemia, nausea
. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #5191283-1
Cetuximab side effect was reported by a Consumer or non-health professional from AUSTRALIA on Nov 01, 2006. Male patient, 70 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, hypocalcaemia, hypomagnesaemia, malaise, neutropenia. Cetuximab dosage: 250 MILLIGRAM/SQ. METER 1/1 WEEK IVD. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5130461-4
Cetuximab side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient died on 02/25/2005.Cetuximab Side Effects Report #5138529-3
Cetuximab side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient died on 02/25/2005.Cetuximab Side Effects Report #4592741-0
Cetuximab side effect was reported by a Health Professional from on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, colon cancer metastatic, confusional state, dyspnoea, hypocalcaemia, hypomagnesaemia, lethargy, malignant neoplasm progression, nausea . Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4633077-9
Cetuximab side effect was reported by a Consumer or non-health professional from on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, dyspnoea, hypocalcaemia, hypomagnesaemia, lethargy, malignant neoplasm progression, nausea . Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4640403-3
Cetuximab side effect was reported by a Consumer or non-health professional from on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, colorectal cancer metastatic, confusional state, dyspnoea, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, lethargy. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4841710-1
Cetuximab side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash
and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4815686-7
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Oct 12, 2005. Male patient, 61 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: electrolyte imbalance, hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, LEUCOVORIN CALCIUM, FLUOROURACIL, ZOMETA. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4840655-0
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Oct 12, 2005. Male patient, 61 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: electrolyte imbalance, hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL, ZOMETA. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4932951-3
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Oct 12, 2005. Male patient, 61 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: electrolyte imbalance, hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL, ZOMETA. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5412342-1
Cetuximab side effect was reported by a Health Professional from GERMANY on June 27, 2007. Female patient, 60 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4604009-4
Cetuximab side effect was reported by a Health Professional from on Feb 28, 2005. Female patient, 60 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypocalcaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #4561325-2
Cetuximab side effect was reported by a Health Professional from on Jan 19, 2005. Male patient, 58 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia. Cetuximab dosage: unknown. Patient recovered.
Cetuximab Side Effects Report #4594749-8
Cetuximab side effect was reported by a Health Professional from on Jan 19, 2005. Male patient, 58 years of age, weighting 169.8 lb, was diagnosed with colorectal cancer metastatic, pain
, insomnia, constipation , rash , nausea and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with HYDROMORPH CONTIN, HYDROMORPHONE, ZOPICLONE, DULCOLAX, DOCUSATE, DALACIN, PROCHLORPERAZINE. Patient recovered.Cetuximab Side Effects Report #5487098-7
Cetuximab side effect was reported by a Health Professional from GERMANY on Oct 05, 2007. Female patient, 53 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia, neutropenia, syncope. Cetuximab dosage: CETUXIMAB 5 MG/ML.. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, OXALIPLATIN. Patient recovered.
Cetuximab Side Effects Report #5331094-7
Cetuximab side effect was reported by a Health Professional from GERMANY on May 16, 2007. Male patient, 52 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient recovered.
Cetuximab Side Effects Report #4664333-6
Cetuximab side effect was reported by a Health Professional from on May 10, 2005. Female patient, 50 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: chest discomfort, colon cancer metastatic, dehydration, diarrhoea, dyspnoea, electrocardiogram t wave inversion, hypomagnesaemia, malignant neoplasm progression, nausea
. Cetuximab dosage: COURSE 2. START DATE 15-MAR-05 (756 MG), 22-MAR TO 19-APR (473MGX5), 26-APR TO 03-MAY-05 (458MG). During the same period patient was treated with VERAPAMIL, THEOPHYLLINE, LORATADINE, ZAFIRLUKAST, SEREVENT, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient recovered.Cetuximab Side Effects Report #4763548-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 10, 2005. Female patient, 50 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: chest discomfort, colon cancer metastatic, dehydration, dyspnoea, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: COURSE 2. START DATE 15-MAR-05 (756 MG), 22-MAR TO 19-APR (473MGX5), 26-APR TO 03-MAY-05 (458MG). During the same period patient was treated with VERAPAMIL, THEOPHYLLINE, LORATADINE, ZAFIRLUKAST, SEREVENT, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient died on 06/21/2005.